Premature ovarian failure

被引：0

作者：

Ludwig M. ^{[1
]}

Strowitzki T. ^{[2
]}

机构：

[1] Zentrum für Hormon- und Stoffwechselerkrankungen, Gynäkologische Endokrinologie und Pränatale Medizin, Endokrinologikum Hamburg, Hamburg

[2] Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsklinikum Heidelberg, 69115 Heidelberg

来源：

Der Gynäkologe | 2010年 / 43卷 / 8期

关键词：

Amenorrhea; Hormone therapy; Hypergonadotropic ovarian insufficiency; POF syndrome; Premature ovarian insufficiency;

D O I：

10.1007/s00129-010-2601-x

中图分类号：

学科分类号：

摘要：

Premature ovarian failure describes different degrees in the gradual decline of the ovarian reserve and activity. The term "premature menopause" or similar descriptions do not describe the clinical problems and consequences sufficiently and should be avoided. A detailed history should be obtained (ovarian surgery, chemotherapy, radiation, family history of early menopause or premature ovarian insufficiency). Furthermore, genetic causes should be clarified (chromosome analysis). Autoimmune diseases must be excluded, since they can be other parts of a polyendocrine syndrome. The therapy with and without family planning is discussed. Hormone therapy has a completely different risk-benefit ratio as compared to peri- or postmenopausal situations. The principles for patient care in this special situation are summarized, since the diagnosis of premature ovarian insufficiency can have a severe impact on the psychological as well as somatic health of the patient. © 2010 Springer-Verlag.

引用

页码：685 / 695

页数：10

共 20 条

[1]

Aziz A., Bergquist C., Nordholm L., Et al., Prophylactic oophorectomy at elective hysterectomy. Effects on psychological well-being at 1-year follow-up and its correlations to sexuality, Maturitas, 51, pp. 349-357, (2005)

[2]

Burgoyne P.S., Baker T.G., Perinatal oocyte loss in X0 mice and its implications for the aetiology of gonadal dysgenesis in XO women, J Reprod Fertil, 75, pp. 633-645, (1985)

[3]

Coulam C.B., Stringfellow S., Hoefnagel D., Evidence for a genetic factor in the etiology of premature ovarian failure, Fertil Steril, 40, pp. 693-695, (1983)

[4]

De Baere E., Beysen D., Oley C., Et al., FOXL2 and BPES: Mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation, Am J Hum Genet, 72, pp. 478-487, (2003)

[5]

Vet A.D., Laven J.S., Jong F.H.D., Et al., Antimullerian hormone serum levels: A putative marker for ovarian aging, Fertil Steril, 77, pp. 357-362, (2002)

[6]

Goswami D., Conway G.S., Premature ovarian failure, Hum Reprod Update, 11, pp. 391-410, (2005)

[7]

Groff A.A., Covington S.N., Halverson L.R., Et al., Assessing the emotional needs of women with spontaneous premature ovarian failure, Fertil Steril, 83, pp. 1734-1741, (2005)

[8]

Harris S.E., Chand A.L., Winship I.M., Et al., Identification of novel mutations in FOXL2 associated with premature ovarian failure, Mol Hum Reprod, 8, pp. 729-733, (2002)

[9]

Lindsay R., Hart D.M., Forrest C., Baird C., Prevention of spinal osteoporosis in oophorectomised women, Lancet, 2, pp. 1151-1154, (1980)

[10]

Lokkegaard E., Jovanovic Z., Heitmann B.L., Et al., The association between early menopause and risk of ischaemic heart disease: Influence of hormone therapy, Maturitas, 53, pp. 226-233, (2006)

← 1 2 →